Author:
Kondakov A. Yu.,Drachyov I. S.,Remizov D. V.,Karamullin M. A.,Tihomirov P. V.,Suprunova E. B.,Yakunchikova E. A.,Danilova O. A.
Reference30 articles.
1. Vasin, M.V., Protivoluchevye lekarstvennye sredstva (Radioprotective Drugs), Moscow, 2010.
2. Gladkikh, V.D., Balandin, N.V., Basharin, V.A., et al., Sostoyanie i perspektivy razvitiya sredstv profilaktiki i lecheniya radiatsionnykh porazhenii (State and Prospects of Development of Means of Prevention and Treatment of Radiation Injuries), Moscow: Kommentarii, 2017.
3. Grebenyuk, A.N. and Gladkikh, V.D., Modern condition and prospects for development of medicines for prevention and early treatment of radiation injures, Radiats. Biol. Radioecol., 2019, vol. 59, no. 2, pp. 132–149. https://doi.org/10.1134/S0869803119020085
4. Simbirtsev, A.S. and Ketlinskii, S.A., Prospects for the use of cytokines and inducers of cytokine synthesis as radioprotective drugs, Radiats. Biol. Radioecol., 2019, vol. 59, no. 2, pp. 170–176. https://doi.org/10.1134/S0869803119020164
5. Rozhdestvensky, L.M., Difficulties in radiation counter measure preparations development in Russia in crisis period: actual approaches searching, Radiats. Biol. Radioecol., 2020, vol. 60, no. 3, pp. 279–290. https://doi.org/10.31857/S086980312003011X